Press Releases
Public Relations: DNAnexus Press
November 10, 2025
New
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform
EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.
Read More
October 22, 2025
DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award
DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.
Read More
September 11, 2025
DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history within Oracle Health EHR.
Read More
August 27, 2025
DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Read More
August 14, 2025
DNAnexus & Boehringer Ingelheim Named 2025 Prix Galien USA Nominee in Best Digital Health Solution for Project PRISM/Project CRYPTx
This recognition highlights an emerging model for dynamic, cloud-based regulatory collaboration.
Read More
May 20, 2025
ARPA-H pioneers game-changing cancer care designed to adapt throughout treatment
Selected performer teams will use predictive models to match treatments with changing tumor biology and prevent disease progression.
Read More
May 01, 2025
Latin-American genetic data available securely to approved researchers worldwide
Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).
Read More
March 24, 2025
DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis
AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform
February 03, 2025
DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration
Companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud
Read More
December 18, 2024
DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, today recognized DNAnexus, provider of the leading enterprise platform for precision health data, with the 2024 Global Enabling Technology Leadership Award in the "bioinformatics-based drug discovery and development industry" category.
Read More
News
January 21, 2026
New
The Top Healthcare Technology CEOs of 2025
The Healthcare Technology Report named DNAnexus CEO Thomas Laur as one of the Top Healthcare Technology CEOs of 2025. He was recognized for his leadership of our advanced platform that speeds critical decisions, reduces administrative drag, and supports research and care delivery across hospitals, employers, payers, and patients.
Read More
January 21, 2026
theCUBE + NYSE Wired: MedTech Unplugged Interview with Thomas Laur
Thomas spoke with theCUBE’s John Furrier as part of the CUBE + NYSE Wired: MedTech Unplugged: The Future of AI in Healthcare & Life Sciences event. They discuss why “omics” is becoming a core data object in modern care and what it takes to make precision medicine operational across the healthcare continuum and why AI’s upside in healthcare depends on more organized, omics-enabled data.
Read More
January 20, 2026
How DNAnexus is enabling precision medicine from research to the point of care
DNAnexus is pushing precision medicine out of research silos to improve care delivery. As CEO Thomas Laur puts it, “The future isn’t moving data into one big bucket. It’s moving algorithms to federated data,” enabling distributed clinical decisions at scale.
Read More
September 12, 2025
DNAnexus and Oracle Health to Integrate Genomic Data into Clinical Care
DNAnexus, Inc., a global provider of a leading enterprise platform for precision health data, has announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications.
Read More
September 11, 2025
DNAnexus, Oracle Partner to Link Genomic Data to Electronic Health Records
DNAnexus has struck an agreement to combine its genomics data infrastructure into Oracle Health's electronic health record (EHR) platform, the companies said on Thursday.
Read More
August 29, 2025
People in the News at DNAnexus, Astrin Biosciences
DNAnexus: Pieter De Leenheer, Todd Oakland, George Asimenos
Read More
February 07, 2025
In Brief This Week: Tempus AI, Myriad Genetics, 23andMe, DNAnexus, Dovetail Genomics
DNAnexus said this week that it has expanded its partnership with life sciences cloud-computing company Veeva Systems to advance cloud-based global regulatory collaboration.
Read More
January 06, 2025
2025 Trends: Multiomics
GEN invited a group of multiomics experts to share their predictions of the potential and needs of multiomics in the near future.
Read More
December 09, 2024
DNAnexus, Panomics Partner to Offer Multiomics Data Analysis Platform for Biopharma Researchers
Bioinformatics firm DNAnexus said Monday that it has inked a partnership with omics data management company Panomics to offer a cloud-based data analysis platform for biopharma customers for biomarker discovery and drug development.
Read More
September 20, 2024
The Rise and Importance of Population-Scale Genome Programs
With the wealth of population-scale projects going on, we have entered a golden age of genomics. Based on efforts such as the All of Us program in the U.S. and the UK Biobank, among many others, we are poised to discover more than we ever knew about natural genetic diversity, what’s considered “normal” human biology, and the continuum of health and disease.